Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
411,726,861
-
Share change
-
+33,815,021
-
Total reported value
-
$3,289,521,260
-
Put/Call ratio
-
32%
-
Price per share
-
$7.99
-
Number of holders
-
107
-
Value change
-
+$287,409,563
-
Number of buys
-
74
-
Number of sells
-
25
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2022
As of 31 Dec 2022 Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 411,726,861 shares of stock of the company.
Largest 10 holders included QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Patient Square Capital LP, Two Seas Capital LP, BlackRock Inc., SC CHINA HOLDING Ltd, and Anchorage Capital Group, L.L.C..
This table shows 107 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.